WHR
36
-10
CRM
49
5
SEE
46
2
INTU
69
2
NEE
54
-3
MSFT
60
5
ETN
87
4
PPG
64
3
HST
49
-3
MMC
48
-3
CPB
42
-3
MAC
71
4
AIZ
66
-2
AEE
41
-4
LYB
55
18
STI
69
-9
AN
58
14
COP
51
-2
XRAY
37
2
QRVO
81
7
WHR
36
-10
CRM
49
5
SEE
46
2
INTU
69
2
NEE
54
-3
MSFT
60
5
ETN
87
4
PPG
64
3
HST
49
-3
MMC
48
-3
CPB
42
-3
MAC
71
4
AIZ
66
-2
AEE
41
-4
LYB
55
18
STI
69
-9
AN
58
14
COP
51
-2
XRAY
37
2
QRVO
81
7
Financhill
Back

Incyte Quote, Financials, Valuation and Earnings

$50 trade to make today with huge potential!

Click here to access my #1 options strategy for overnight wins starting with $50!
Buy
52

INCY
Incyte

Last Price:
51.72
Seasonality Move:
13.19%

7 Day Trial

ALL ACCESS PASS

$ 7

DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon

Discover our top DeFi pick for potentially massive gains now (before it's too late).

Incyte Price Quote

$51.72
+0.04 (+1.06%)
(Updated: April 27, 2024 at 6:09 AM ET)

Incyte Key Stats

Buy
52
Incyte (INCY) is a Buy
Day range:
$50.87 - $51.85
52-week range:
$50.27 - $75.74
Dividend yield:
0%
P/E ratio:
19.50
P/S ratio:
3.16
P/B ratio:
2.24%
Volume:
1.6M
Avg. volume:
1.8M
1-year change:
-29.72%
Market cap:
$11.6B
Revenue:
$3.7B
EPS:
$2.65

How Much Does Incyte Make?

  • How Much Are Incyte's Sales Annually?
    INCY Revenues are $3.7B
  • How Much Profit Does Incyte's Make A Year?
    INCY net income is $597.6M

Is Incyte Growing As A Company?

  • What Is Incyte's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.09%
  • What Is Incyte's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 5.85%

Incyte Stock Price Performance

  • Did Incyte Stock Go Up Last Month?
    Incyte share price went down by -8.61% last month
  • Did INCY's Share Price Rise Over The Last Year?
    INCY share price fell by -29.72% over the past 1 year

What Is Incyte 52-Week High & Low?

  • What Is Incyte’s 52-Week High Share Price?
    Incyte has traded as high as $75.74 over the past 52 weeks
  • What Is Incyte’s 52-Week Low Share Price?
    Incyte has traded as low as $50.27 over the past 52 weeks

Incyte Price To Free Cash Flow

  • Is Incyte Stock Overvalued?
    Incyte is trading at a price to free cash flow ratio of 26.01
  • Is Incyte Stock Undervalued?
    Incyte EV to Free Cash Flow ratio is 17.70
  • What Is Incyte’s Price Earnings Growth Ratio?
    INCY PEG ratio is 0.26
  • Is Incyte Trading At A Premium To Earnings?
    Incyte EV to EBIT ratio is 9.50

Is It Risky To Buy Incyte?

  • How Much Debt Does Incyte Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Incyte Have?
    Cash and short term investments quarterly total is $3.7B
  • What Is Incyte’s Book Value Per Share?
    Book value per share is 23.14

Is Incyte Cash Flow Positive?

  • What Is INCY Cash Flow From Operations?
    Cash flow from operations (TTM) is $496.5M
  • What Is Incyte’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$20M
  • What Is Incyte’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$207.7M

Incyte Return On Invested Capital

  • Is Management Doing A Good Job?
    INCY return on invested capital is 12.61%
  • What Is Incyte Return On Assets?
    ROA measures how assets are converting to revenues and is 9.63%
  • What Is INCY Return On Equity?
    ROE is a measure of profitability and is 12.61%

Incyte Earnings Date & Stock Price

  • What Is Incyte's Stock Price Today?
    A single share of INCY can be purchased today for 51.68
  • What Is Incyte’s Stock Symbol?
    Incyte trades on the nasdaq under the ticker symbol: INCY
  • When Is Incyte’s Next Earnings Date?
    The next quarterly earnings date for Incyte is scheduled on April 30, 2024
  • When Is INCY's next ex-dividend date?
    Incyte's next ex-dividend date is May 7, 2020
  • How To Buy Incyte Stock?
    You can buy Incyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Incyte Competitors

  • Who Are Incyte's Competitors?
    Below is a list of companies who compete with Incyte or are related in some way:
    • Biogen Inc (BIIB)
    • Illumina Inc (ILMN)
    • MorphoSys AG (MOR)
    • Novartis AG (NVS)
    • Pfizer Inc (PFE)

Incyte Dividend Yield

Data Unavailable

Incyte Analyst Estimates

YoY Growth Past Surprise
EPS: 584.62% -7.72%
Revenue: 9.35% 0.99%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 12
Sell Recommendations: 0
Price Target: 75.58
Upside from Last Price: 46.25%

Major Shareholders

  • How many INCY shares are owned by institutional investors?
    329.1M INCY shares are owned by institutional investors
  • How many INCY shares are owned by insiders?
    3.9M INCY shares are owned by insiders